Pharmacological Reviews Get Tables of Contents delivered automatically
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     



0031-6997/06/5802-259-279$7.00
Pharmacol Rev 58:259-279, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction
Right arrow An erratum has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zheng, C. J.
Right arrow Articles by Chen, Y. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, C. J.
Right arrow Articles by Chen, Y. Z.

Review Article

Therapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics

C. J. Zheng, L. Y. Han, C. W. Yap, Z. L. Ji, Z. W. Cao and Y. Z. Chen

Bioinformatics and Drug Design Group, Department of Computational Science, National University of Singapore, Singapore, Singapore

Abstract
I. Introduction
II. Distribution of Therapeutic Targets with Respect to Disease Classes
    A. General Distribution Pattern
    B. Targets for the Treatment of Diseases in Multiple Classes
    C. Research Targets
III. Current Trends in Exploration of Therapeutic Targets
    A. Targets of Investigational Agents in United States Patents Approved in 2000 through 2004
    B. Progress and Difficulties in Target Exploration
    C. Targets of Subtype-Specific Drugs
IV. Characteristics of Therapeutic Targets
    A. What Constitutes a Therapeutic Target?
    B. Protein Families Represented by Therapeutic Targets
    C. Structural Folds
    D. Biochemical Classes
    E. Human Proteins Similar to Therapeutic Targets
    F. Associated Pathways
    G. Tissue Distribution
    H. Chromosome Locations
V. Can Druggable Proteins Be Predicted from Their Sequence?
    A. ''Rules'' for Guiding the Search for Druggable Proteins
    B. Prediction of Druggable Proteins by a Statistical Learning Method
Abstract

Modern drug discovery is primarily based on the search and subsequent testing of drug candidates acting on a preselected therapeutic target. Progress in genomics, protein structure, proteomics, and disease mechanisms has led to a growing interest in and effort for finding new targets and more effective exploration of existing targets. The number of reported targets of marketed and investigational drugs has significantly increased in the past 8 years. There are 1535 targets collected in the therapeutic target database compared with ~500 targets reported in a 1996 review. Knowledge of these targets is helpful for molecular dissection of the mechanism of action of drugs and for predicting features that guide new drug design and the search for new targets. This article summarizes the progress of target exploration and investigates the characteristics of the currently explored targets to analyze their sequence, structure, family representation, pathway association, tissue distribution, and genome location features for finding clues useful for searching for new targets. Possible "rules" to guide the search for druggable proteins and the feasibility of using a statistical learning method for predicting druggable proteins directly from their sequences are discussed.


Address correspondence to: Dr. Chen Yu Zong, Department of Pharmacy, Science Faculty, National University of Singapore, Blk S16, Level 8, 08-14, 3 Science Drive 2, Singapore 117543, Singapore. E-mail: phacyz{at}nus.edu.sg




This article has been cited by other articles:


Home page
BioinformaticsHome page
A. L. Mayburd, I. Golovchikova, and J. L. Mulshine
Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets
Bioinformatics, February 1, 2008; 24(3): 389 - 395.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Q. Tang, L. Y. Han, H. H. Lin, J. Cui, J. Jia, B. C. Low, B. W. Li, and Y. Z. Chen
Derivation of Stable Microarray Cancer-Differentiating Signatures Using Consensus Scoring of Multiple Random Sampling and Gene-Ranking Consistency Evaluation
Cancer Res., October 15, 2007; 67(20): 9996 - 10003.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
J.-X. Zhang, W.-J. Huang, J.-H. Zeng, W.-H. Huang, Y. Wang, R. Zhao, B.-C. Han, Q.-F. Liu, Y.-Z. Chen, and Z.-L. Ji
DITOP: drug-induced toxicity related protein database
Bioinformatics, July 1, 2007; 23(13): 1710 - 1712.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition
Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics